Citizens Financial Group Inc Bristol Myers Squibb CO Transaction History

Citizens Financial Group Inc

$4.97 Billion
Q1 2025

A detailed history of Citizens Financial Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Citizens Financial Group Inc holds 35,337 shares of BMY stock, worth $1.65 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

35,337

Previous 29,942 18.02%

Holding current value

$1.65 Million

Previous $1.69 Million 27.29%

% of portfolio

0.04%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$53.9 - $63.11 $290,790 - $340,478	5,395 Added 18.02%	35,337 $2.16 Million
Q4 2024 Feb 07, 2025	SELL	$51.92 - $59.94 $158,511 - $182,996	-3,053 Reduced 9.25%	29,942 $1.69 Million
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $87,569 - $114,264	-2,208 Reduced 6.27%	32,995 $1.71 Million
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $324,817 - $427,629	8,070 Added 29.74%	35,203 $1.46 Million
Q1 2024 May 17, 2024	SELL	$47.98 - $54.4 $26,868 - $30,464	-560 Reduced 2.02%	27,133 $1.47 Million
Q4 2023 Feb 02, 2024	BUY	$48.48 - $57.85 $79,798 - $95,221	1,646 Added 6.32%	27,693 $1.42 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $195,552 - $218,657	-3,378 Reduced 11.48%	26,047 $1.51 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $42,685 - $47,395	670 Added 2.33%	29,425 $1.88 Million
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $3,285 - $3,726	-50 Reduced 0.17%	28,755 $1.99 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $148,875 - $176,289	-2,174 Reduced 7.02%	28,805 $2.07 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $40 - $23,743	309 Added 1.01%	30,979 $2.2 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $228,535 - $251,697	3,147 Added 11.43%	30,670 $2.36 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $56,869 - $68,191	-925 Reduced 3.25%	27,523 $2.01 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $148,984 - $173,680	-2,778 Reduced 8.9%	28,448 $1.75 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $79,701 - $93,360	-1,347 Reduced 4.14%	31,226 $1.85 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $67,110 - $73,083	1,084 Added 3.44%	32,573 $2.18 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $31,568 - $35,505	532 Added 1.72%	31,489 $1.99 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $72,810 - $82,507	-1,261 Reduced 3.91%	30,957 $1.92 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $62,598 - $69,367	1,090 Added 3.5%	32,218 $1.93 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $104,541 - $122,219	-1,907 Reduced 5.77%	31,128 $1.83 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $66,676 - $96,896	-1,437 Reduced 4.17%	33,035 $1.84 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $252,496 - $329,358	5,131 Added 17.49%	34,472 $2.21 Million
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $21,128 - $25,050	-494 Reduced 1.66%	29,341 $1.49 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $93,969 - $103,910	-2,106 Reduced 6.59%	29,835 $1.35 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $144,609 - $172,429	-3,205 Reduced 9.12%	31,941 $1.52 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $113,854 - $147,642	-2,335 Reduced 6.23%	35,146 $1.83 Million
Q3 2018 Nov 02, 2018	SELL	$55.19 - $62.25 $60,598 - $68,350	-1,098 Reduced 2.85%	37,481 $2.33 Million
Q2 2018 Jul 27, 2018	SELL	$50.53 - $62.98 $7.76 Million - $9.67 Million	-153,579 Reduced 79.92%	38,579 $2.14 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $560,371 - $645,100	-9,352 Reduced 4.64%	192,158 $12.2 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $2.77 Million - $3.02 Million	46,172 Added 29.72%	201,510 $12.3 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $254,168 - $293,331	-4,602 Reduced 2.88%	155,338 $9.9 Million
Q2 2017 Aug 10, 2017	BUY	N/A	159,940	159,940 $8.91 Million

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Bristol Myers Squibb CO Transaction History